223 related articles for article (PubMed ID: 19778527)
41. Serum free light chain analysis.
Davids MS; Murali MR; Kuter DJ
Am J Hematol; 2010 Oct; 85(10):787-90. PubMed ID: 20721885
[TBL] [Abstract][Full Text] [Related]
42. [Serum free light chains for diagnosis and follow-up of multiple myeloma].
Jung S; Kim M; Lim J; Kim Y; Han K; Min CK; Min WS
Korean J Lab Med; 2008 Jun; 28(3):169-73. PubMed ID: 18594166
[TBL] [Abstract][Full Text] [Related]
43. Quantification of serum free light chain kappa and lambda by the SPAPLUS analyser.
Maisin D; Lepoutre T; Gruson D; Wallemacq P
Clin Biochem; 2013 May; 46(7-8):622-6. PubMed ID: 23291296
[TBL] [Abstract][Full Text] [Related]
44. Assessment of serum free light chain levels in healthy adults immediately after marathon running.
Campbell JP; Eijsvogels TM; Wang Y; Hopman MT; Jacobs JF
Clin Chem Lab Med; 2016 Mar; 54(3):459-65. PubMed ID: 26351935
[TBL] [Abstract][Full Text] [Related]
45. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.
Boyle EM; Fouquet G; Guidez S; Bonnet S; Demarquette H; Dulery R; Herbaux C; Noel MP; Manier S; Schraen S; Onraed B; Faucompré JL; Hennache B; Petillon MO; Mathiot C; Avet-Loiseau H; Facon T; Harding SJ; Moreau P; Leleu X
Cancer; 2014 Dec; 120(24):3952-7. PubMed ID: 25116271
[TBL] [Abstract][Full Text] [Related]
46. Hemodiafiltration improves free light chain removal and normalizes κ/λ ratio in hemodialysis patients.
Bourguignon C; Chenine L; Bargnoux AS; Leray-Moragues H; Canaud B; Cristol JP; Morena M
J Nephrol; 2016 Apr; 29(2):251-257. PubMed ID: 26022721
[TBL] [Abstract][Full Text] [Related]
47. Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.
Abe M; Goto T; Kosaka M; Wolfenbarger D; Weiss DT; Solomon A
Clin Exp Immunol; 1998 Feb; 111(2):457-62. PubMed ID: 9486419
[TBL] [Abstract][Full Text] [Related]
48. Combined analysis using extended renal reference range of serum free light chain ratio and serum protein electrophoresis improves the diagnostic accuracy of multiple myeloma in renal insufficiency.
Park JW; Kim YK; Bae EH; Ma SK; Kim SW
Clin Biochem; 2012 Jul; 45(10-11):740-4. PubMed ID: 22503879
[TBL] [Abstract][Full Text] [Related]
49. Serum free light chain analysis may miss monoclonal light chains that urine immunofixation electrophoreses would detect.
Shaheen SP; Levinson SS
Clin Chim Acta; 2009 Aug; 406(1-2):162-6. PubMed ID: 19410572
[TBL] [Abstract][Full Text] [Related]
50. Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma.
Nowrousian MR; Brandhorst D; Sammet C; Kellert M; Daniels R; Schuett P; Poser M; Mueller S; Ebeling P; Welt A; Bradwell AR; Buttkereit U; Opalka B; Flasshove M; Moritz T; Seeber S
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8706-14. PubMed ID: 16361557
[TBL] [Abstract][Full Text] [Related]
51. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.
Eisele L; Dürig J; Hüttmann A; Dührsen U; Assert R; Bokhof B; Erbel R; Mann K; Jöckel KH; Moebus S;
Ann Hematol; 2012 Feb; 91(2):243-8. PubMed ID: 21789623
[TBL] [Abstract][Full Text] [Related]
52. [New possibilities of the diagnosis and monitoring of the course of AL-amyloidosis].
Rameev VV; Kozlovskaia LV; Kogarko IN; Kogarko BS
Ter Arkh; 2010; 82(6):29-32. PubMed ID: 20731106
[TBL] [Abstract][Full Text] [Related]
53. Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias.
Ozsan GH; Dispenzieri A
Expert Rev Clin Immunol; 2011 Jan; 7(1):65-73. PubMed ID: 21162651
[TBL] [Abstract][Full Text] [Related]
54. Effects of Long-Term Storage on Serum Free Light Chain Stability.
Hörber S; Klein R; Peter A
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238
[TBL] [Abstract][Full Text] [Related]
55. Application of Capillary Electrophoresis in Monoclonal Gammopathies and the Cutoff Value of Monoclonal Protein in Differential Diagnosis of Multiple Myeloma and Other Monoclonal Gammopathies.
Cao F; Zhang R; Xu L; Liu M; Yuan Y
Ann Clin Lab Sci; 2021 May; 51(3):400-407. PubMed ID: 34162571
[TBL] [Abstract][Full Text] [Related]
56. [Analysis of serum free light chains κ/λ ratio and heavy/light chain pairs of immunoglobulin to the stratification of multiple myeloma according to Mayo Stratification of Myeloma and Revised International Staging System].
Ščudla V; Balcárková J; Lochman P; Vincová M; Pika T; Minařík J; Zapletalová J; Jarošová M
Vnitr Lek; 2016 Apr; 62(4):269-80. PubMed ID: 27250604
[TBL] [Abstract][Full Text] [Related]
57. [Usefulness of serum free light-chain assay for evaluation of therapeutic efficacy in non-secretory multiple myeloma].
Maruyama Y; Hayashi T; Ikeda H; Yasui H; Ishida T; Shinomura Y
Rinsho Ketsueki; 2013 Jan; 54(1):122-6. PubMed ID: 23391656
[TBL] [Abstract][Full Text] [Related]
58. A novel approach for the purification and proteomic analysis of pathogenic immunoglobulin free light chains from serum.
Lavatelli F; Brambilla F; Valentini V; Rognoni P; Casarini S; Di Silvestre D; Perfetti V; Palladini G; Sarais G; Mauri P; Merlini G
Biochim Biophys Acta; 2011 Mar; 1814(3):409-19. PubMed ID: 21215335
[TBL] [Abstract][Full Text] [Related]
59. Polyclonal immunoglobulin free light chain levels predict survival in myeloid neoplasms.
Pardanani A; Lasho TL; Finke CM; Rajkumar SV; Singh PP; Ketterling RP; Hanson CA; Katzmann JA; Tefferi A
J Clin Oncol; 2012 Apr; 30(10):1087-94. PubMed ID: 22331938
[TBL] [Abstract][Full Text] [Related]
60. [Immunonephelometric analysis of immunoglobulin light chains: agreement between the theoretical and experimental model. Assessment of the reference values of the kappa/lambda ratio and the heavy to light chain ratio].
Chapuis-Cellier C; Cloppet H; Chazaud A; Coquelin H
J Pharm Belg; 1996; 51(1):23-27. PubMed ID: 8882446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]